PRA International Experts to Chair BioPharma Asia Panels

Drug Development Strategies for South Korea and India

Mar 29, 2011, 09:00 ET from PRA International

RALEIGH, N.C., March 29, 2011 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces that two of our operational experts will conduct country-focused roundtable sessions at the 4th Annual BioPharma Asia Convention being held in Singapore 28-31 March 2011. PRA will also host an exhibit at booth A01.

Day two of the convention will feature interactive roundtables exploring drug development concerns in six key Asian countries. PRA's Dr. Yooni Kim, Senior Manager of Clinical Operations, will lead the South Korea roundtable, while Dr. Pramod Kabra, Director of Clinical Operations, will conduct the India session. Attendees will have the opportunity to exchange ideas with the hosts and gain further insight into country-specific innovations, policies and strategies.

Dr. Kim, based in PRA's Seoul office, has over 10 years of clinical research experience with major pharmaceutical companies and as a researcher at the Seoul National University Hospital Clinical Trial Center. She also serves on the advisory task force at KFDA, South Korea's regulatory authority.

Working from PRA's office in Mumbai, Dr. Kabra has nearly 15 years of experience in the pharmaceutical and CRO industries, including clinical practice, bioequivalence and Phase I - IV studies. He has coordinated and monitored approximately 100 clinical studies across various therapeutic areas. 

Additional PRA representatives from our Clinical Operations and Business Development groups will be available to discuss our capabilities in Asia and successful approach to drug development. Since 2008, PRA has participated in more than 115 studies in the region, and we have been strategically expanding our presence there for more than a decade. PRA has offices in South Korea, India, Taiwan, China and Hong Kong.

About PRA

PRA conducts clinical trials across all therapeutic areas in more than 80 countries and provides services in all phases of clinical development through its 39 global offices.

PRA's therapeutic expertise, global reach and project experience combined with its extensive local knowledge and differentiating philosophy—THE PERSONAL ELEMENT— enable its project teams to deliver consistent and on-time performance. This unique PRA philosophy recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to be innovative and to use their personal commitment to accelerate the development life cycle.

To learn more about PRA International, please visit, email or call our Global Headquarters at +1 (919) 786-8200.

SOURCE PRA International